Wen Guan

577 total citations
20 papers, 273 citations indexed

About

Wen Guan is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Wen Guan has authored 20 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Wen Guan's work include Distributed and Parallel Computing Systems (2 papers), MicroRNA in disease regulation (2 papers) and RNA modifications and cancer (2 papers). Wen Guan is often cited by papers focused on Distributed and Parallel Computing Systems (2 papers), MicroRNA in disease regulation (2 papers) and RNA modifications and cancer (2 papers). Wen Guan collaborates with scholars based in China, Hong Kong and United States. Wen Guan's co-authors include Shulan Yang, Haihe Wang, Wenliang Zhang, Shaoyang Zhang, Gcf Chan, Jing Mo, Binghui Zeng, Yanjie Wei, Qianshen Zhang and Chun‐Xia Zeng and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Wen Guan

20 papers receiving 271 citations

Peers

Wen Guan

ONCOL

EPIDE

PRM

Sen-Hao Xiao China

Jesús García‐Cano Spain

Xiuyi Yu China

Viacheslav V. Senichkin Sweden

Kiera Walker United States

Nikolai D. Aksenov Russia

Yizhe Wang China

Ethan Ahler United States

Andreas U. Lindner Ireland

Tomoko Ueda Japan

Sen-Hao Xiao China

Wen Guan

234 ×1.3

65 ×0.8

35 ×0.7

ONCOL

21 ×0.6

EPIDE

17 ×0.6

PRM

Citations per year, relative to Wen Guan Wen Guan (= 1×) peers Sen-Hao Xiao

Countries citing papers authored by Wen Guan

Since Specialization

Citations

This map shows the geographic impact of Wen Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Guan more than expected).

Fields of papers citing papers by Wen Guan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Guan. The network helps show where Wen Guan may publish in the future.

Co-authorship network of co-authors of Wen Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Guan. A scholar is included among the top collaborators of Wen Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Guan. Wen Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guan, Wen, Jingjing Li, Tianjie Pu, et al.. (2025). PlexinD1 is a driver and a therapeutic target in advanced prostate cancer. EMBO Molecular Medicine. 17(2). 336–364. 1 indexed citations

Maeno, T., K. De, Wen Guan, et al.. (2024). Utilizing Distributed Heterogeneous Computing with PanDA in ATLAS. SHILAP Revista de lepidopterología. 295. 4053–4053. 1 indexed citations

Guan, Wen, T. Maeno, R. Zhang, et al.. (2024). Distributed Machine Learning Workflow with PanDA and iDDS in LHC ATLAS. SHILAP Revista de lepidopterología. 295. 4019–4019. 1 indexed citations

Wang, Jing, et al.. (2024). Abstract 2011: MAOA Drives Anti Androgen Therapy Resistance in Advanced Prostate Cancer by Conferring Neuroendocrine Plasticity via a Twist1 BRN2 Signaling Pathway. Cancer Research. 84(6_Supplement). 2011–2011. 1 indexed citations

Li, Gang, Yali Zhang, Huamin Wang, et al.. (2023). Research progress on phosphatidylinositol 4-kinase inhibitors. Biochemical Pharmacology. 220. 115993–115993. 8 indexed citations

Yang, Jing, Yonggang Wang, Wen Guan, et al.. (2022). Spiral molecules with antimalarial activities: A review. European Journal of Medicinal Chemistry. 237. 114361–114361. 14 indexed citations

Wei, Qing, et al.. (2021). 1414P Helicobacter pylori infection is associated with clinical benefits of anti-PD-1/PD-L1-based therapies in advanced gastric/esophagogastric junction cancer: A real world multicenter observational study. Annals of Oncology. 32. S1061–S1062. 1 indexed citations

Zhang, Shaoyang, Hui Li, Wen Guan, et al.. (2021). Adaptor SH3BGRL drives autophagy-mediated chemoresistance through promoting PIK3C3 translation and ATG12 stability in breast cancers. Autophagy. 18(8). 1822–1840. 27 indexed citations

Zhang, Wenliang, Binghui Zeng, Huancai Lin, et al.. (2021). CanImmunother: a manually curated database for identification of cancer immunotherapies associating with biomarkers, targets, and clinical effects. OncoImmunology. 10(1). 1944553–1944553. 5 indexed citations

10.

Zhang, Wenliang, Yan Zhang, Jing Mo, et al.. (2021). COVID19db: a comprehensive database platform to discover potential drugs and targets of COVID-19 at whole transcriptomic scale. Nucleic Acids Research. 50(D1). D747–D757. 25 indexed citations

11.

Zhang, Wenliang, Yang Liu, Guodong Liang, et al.. (2021). circMine: a comprehensive database to integrate, analyze and visualize human disease–related circRNA transcriptome. Nucleic Acids Research. 50(D1). D83–D92. 40 indexed citations

12.

Zhang, Wenliang, Shaoyang Zhang, Wen Guan, et al.. (2020). Poly C Binding Protein 1 Regulates p62/SQSTM1 mRNA Stability and Autophagic Degradation to Repress Tumor Progression. Frontiers in Genetics. 11. 930–930. 16 indexed citations

13.

Li, Hui, Yanli Wei, Wen Guan, et al.. (2020). SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane. Journal of Experimental & Clinical Cancer Research. 39(1). 81–81. 14 indexed citations

14.

Wei, Yanli, Yanbin Liu, Wen Guan, et al.. (2019). Metastatic Phosphatase PRL-3 Induces Ovarian Cancer Stem Cell Sub-population through Phosphatase-Independent Deacetylation Modulations. iScience. 23(1). 100766–100766. 13 indexed citations

15.

Yu, Xiaolan, Jianping Lu, Jingjing Li, et al.. (2019). Serum Triglyceride Lipase Concentrations are Independent Risk Factors for Coronary Artery Disease and In-Stent Restenosis. Journal of Atherosclerosis and Thrombosis. 26(9). 762–774. 9 indexed citations

16.

Yu, Xiaolan, et al.. (2019). Large-scale gene analysis of rabbit atherosclerosis to discover new biomarkers for coronary artery disease. Open Biology. 9(1). 180238–180238. 4 indexed citations

17.

Li, Hui, Wen Guan, Xiaomei Zhang, et al.. (2018). PCBP1 depletion promotes tumorigenesis through attenuation of p27Kip1 mRNA stability and translation. Journal of Experimental & Clinical Cancer Research. 37(1). 187–187. 48 indexed citations

18.

Xu, Limei, Hui Li, Wen Guan, et al.. (2017). SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia. Leukemia & lymphoma. 59(4). 918–930. 12 indexed citations

19.

Tong, Fang, Xiaoling Guo, Li Li, et al.. (2016). Expression patterns of SH3BGR family members in zebrafish development. Development Genes and Evolution. 226(4). 287–295. 17 indexed citations

20.

Wang, Xia, Jin Gao, Jing Gao, et al.. (2014). Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosis. Anti-Cancer Drugs. 26(1). 35–45. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact